PATIENTS + PROFITABILITY™ EXPERT | STRATEGIC EXECUTIVE

WHERE PATIENT OUTCOMES
AND PROFITABILITY ALIGN.

Innovation only continues if companies remain profitable enough to fund the next breakthrough.

Patrick R. Coyle - Patients + Profitability Expert

$5B+

Portfolio Leadership

Commercial Strategy & Financial Leadership

$3B+

Annual Revenue

Commercial Operations Managed

25+

Years Leadership

Executive Finance & Technology Experience

18+

Years in Life Sciences

Global Commercialization & Market Access

Trusted Experience Across Leading Life Sciences Organizations
Bayer
Novartis
Eisai
IQVIA
Insmed
Deloitte
Sun Chemical
Computer Horizons Corp
Novus Proximus
Bayer
Novartis
Eisai
IQVIA
Insmed
Deloitte
Sun Chemical
Computer Horizons Corp
Novus Proximus

Transforming Commercial Complexity into Patient & Business Success

The greatest commercialization challenges rarely stem from a single function. They emerge when Commercial, Finance, Market Access, Patient Support, and Clinical teams operate with different priorities. Patrick Coyle helps organizations align these functions around one shared objective—improving patient access while protecting sustainable business performance through the Patients + Profitability™ framework.

Challenges

Who This Is Relevant For

You're launching a new therapy.

You manage profitability.

You improve patient access.

You care for patients every day.

You're navigating the healthcare system.

You're shaping healthcare innovation.

WHY ORGANIZATIONS TRUST PATRICK

25+ Years at the Intersection of
Finance, Pharmaceutical Commercialization, and Technology

Patrick R. Coyle has spent two decades helping life sciences organizations improve patient access, strengthen commercialization strategies, and optimize financial performance.

$1B+

Brands Supported

Supported blockbuster and specialty pharmaceutical brands across commercialization, market access, and financial strategy.

Global

Commercialization Leadership

Led cross-functional commercialization and market access initiatives across global life sciences organizations.

Former CFO

Eisai Americas

Oversaw financial strategy, business performance, and commercial operations for the Americas organization.

Former Leader

Bayer Oncology Finance

Guided oncology finance strategy, forecasting, and commercialization planning for high-impact therapies.

Former GTN Leader

IQVIA

Directed Gross-to-Net strategy, pricing analytics, and market access solutions for pharmaceutical clients.

Founder

NextGen GTN
NextGen GTN™

Created the Patients + Profitability™ framework to help organizations align commercial, finance, and patient access teams.

THE PHILOSOPHY

What Is Patients + Profitability™?

Patients + Profitability™ is a commercialization philosophy built on a simple observation:

Patient Friction Creates Revenue Leakage.

The most successful pharmaceutical organizations recognize that improving patient access and improving business performance are often the same objective viewed from different perspectives.

Every prescription begins with hope.

Every patient begins a journey.

Every organization manages profitability.

The leaders who understand both create better outcomes for patients and stronger outcomes for their organizations.

THE MISSION

Connecting the Patient Journey and the Commercial Journey

Patients + Profitability™ exists to connect the patient journey and the commercial journey.

For more than 25 years, Patrick R. Coyle has worked at the intersection of patient access, pharmaceutical finance, commercialization strategy, specialty distribution, and profitability optimization.

  • 01Understand Where Patients Are Lost
  • 02Understand Where Profitability Leaks
  • 03Build Solutions That Improve Both

Patients + Profitability™

The most successful pharmaceutical organizations recognize that patient access and financial performance are not competing priorities—they are interconnected drivers of sustainable growth.

THE PODCAST

Patients + Profitability™

Conversations about what happens between the prescription and the patient.

THE TWO JOURNEYS

Patients + Profitability™

Every patient travels through two journeys at once.

One is visible—the appointments, diagnoses, prescriptions, and treatments that define the path to therapy. The other is invisible—the fear, hope, and resilience behind every decision, rarely captured in any report.

Patients + Profitability™ holds that these journeys are inseparable. Understanding both together improves patient access, strengthens outcomes, and builds more sustainable healthcare experiences.

Book a Discovery Call
FOUNDED BY PATRICK R. COYLE

NextGen GTN™

Understanding Commercialization Through Patients + Profitability™

NextGen GTN™ helps Commercial, Market Access, Revenue, and Finance teams build a shared understanding of commercialization so operational reality and financial recognition remain aligned.

8 Educational Webinars
4 Alignment Labs
2 E-Books
Visit NextGen GTN™ →

Explore More Services

CFO Advisory

Financial Navigation

Executive finance leadership for growth-stage life sciences companies requiring strategic direction, investor confidence, and board-level financial stewardship.

Explore Financial Navigation
GTN Advisory

Life Science Advisory

Transform Gross-to-Net from operational complexity into strategic advantage through forecasting, accrual governance, reconciliation, and audit-ready controls.

Explore Life Science Advisory
Transformation

Financial Transformation

Modernize systems, processes, and operating models to improve visibility, accelerate close cycles, and support scalable growth.

Explore Financial Transformation
EXECUTIVE ENDORSEMENTS

Trusted by Finance & Commercial Leaders Across Life Sciences